Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » New drug prevents vision loss
 

New drug prevents vision loss

A new FDA approved drug called Macugen promises to slow vision loss and reduce the risk of blindness in older patients suffering from the wet form of age-related macular degeneration (AMD). AMD is the primary cause of vision loss in people over 55 and the wet form occurs in 10% of cases. However, the wet form accounts for 90% of severe vision loss due to AMD. The growth of abnormal, leaky blood vessels below the retina causes wet AMD. The leaking vessels damage the central vision. Mucagen stops the development of leaky blood vessels by blocking the vascular endothelial growth factor which causes it. Without treatment, all of central vision may be lost (near blindness) but peripheral vision will still be working. During studies, the drug was capable of stabilizing vision and in some causes even moderately improving it. Side effects include retinal detachment, eye lens injury and infection.

Source: summary of medical news story as reported by Web MD Medical News

Related Disease Topics:

Related Symptom Topics:

  • Leaking eye vessels

Article Source Details

About: New drug prevents vision loss

Date: 29 December 2004

Source: Web MD Medical News

Author: Jennifer Warner

URL: http://my.webmd.com/content/article/98/105025.htm

Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Diabetes vaccine may prevent diabetes in children at risk
  • Diabetes: the simple facts
  • Diabetic and complications
  • Diabetic blindness may be prevented by taking aspirin
  • Diabetic children need to use continuous glucose monitoring to achieve good control of their condition
  • Diabetic eye problems
  • Diabetic injected with wrong medication in a nursing home
  • Diabetic neuropathic pain alleviated with common nutrient
  • Diabetic neuropathy causal link
  • Diabetic women don't fare as well as diabetic men following a stenting procedure
  • Diabetics are more prone to the potentially fatal bacteremia and sepsis
  • Diabetics face greater rates of mortality and post-surgical complications following coronary bypass
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise